Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,569 | -135,020 | -86,064 | -41,518 | -143,948 |
| Depreciation Amortization | 5,140 | 12,125 | 7,979 | 3,888 | 8,233 |
| Accounts payable and accrued liabilities | 5,209 | -2,376 | -3,471 | -930 | 1,614 |
| Other Working Capital | -18,401 | -18,850 | -16,149 | -10,213 | 20,121 |
| Other Operating Activity | 29,037 | 20,288 | 16,049 | 6,822 | 32,615 |
| Operating Cash Flow | $-172,584 | $-123,833 | $-81,656 | $-41,951 | $-81,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,273 | -7,168 | -4,821 | -2,884 | -8,401 |
| Purchase Of Investment | -707,953 | -409,738 | -279,921 | -54,803 | -246,334 |
| Sale Of Investment | 459,513 | 300,010 | 189,185 | 93,200 | 323,036 |
| Investing Cash Flow | $-257,713 | $-116,896 | $-95,557 | $35,513 | $68,301 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 296,950 | 285,161 | 239,391 | 1,624 | 3,217 |
| Common Stock Repurchased | -15 | -15 | -15 | N/A | N/A |
| Other Financing Activity | 188,732 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $485,667 | $285,146 | $239,376 | $1,624 | $3,217 |
| Beginning Cash Position | 55,528 | 55,528 | 55,528 | 55,528 | 65,375 |
| End Cash Position | 110,898 | 99,945 | 117,691 | 50,714 | 55,528 |
| Net Cash Flow | $55,370 | $44,417 | $62,163 | $-4,814 | $-9,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,584 | -123,833 | -81,656 | -41,951 | -81,365 |
| Capital Expenditure | -9,273 | -7,168 | -4,821 | -2,884 | -8,401 |
| Free Cash Flow | -181,857 | -131,001 | -86,477 | -44,835 | -89,766 |